Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Europa Stream

 

Bavarian Nordic board tries to push shareholders to accept Nordic Capital-led take-private

A consortium made up of two private equity firms, Nordic Capital and Permira, is trying to buy out Danish vaccine maker Bavarian Nordic and take it off the stock market. Bavarian Nordic’s board is keen for shareholders to accept, but not enough shareholders accepted the initial offer made in August. Nordic Capital and Permira have now made a sweetened offer, and lowered the percentage of shares that have to accept it in order for the offer to proceed from 75% to two thirds of the total.
October 23, 2025

EQT exits ImCheck Therapeutics following Ipsen’s €1 billion acquisition deal

EQT Life Sciences, the healthcare investment arm of Swedish private equity firm EQT, has exited Marseille-based biotech ImCheck Therapeutics. ImCheck, which develops immuno-oncology therapies targeting butyrophilins, a novel family of immune-regulating proteins, has agreed to be acquired by Paris-headquartered biopharmaceutical company Ipsen in a deal worth up to €1 billion. The deal underscores growing interest in European immunotherapy innovation, driven by patent cliff pressures, favourable valuation dynamics compared to US assets, and Europe’s maturing research ecosystem, which now produces around 40% of global scientific citations.
October 23, 2025

Smart ring maker Ōura raises $900 million

Finnish health tracking ring maker Ōura has raised over $900 million in a funding round led by US-based asset manager Fidelity Management, with participation from new investor ICONIQ, based in California, and existing backers Whale Rock and Atreides, both Boston-based investment firms
October 23, 2025

UK’s CoMind raises $100m+ to advance non-invasive brain monitoring

CoMind, a London-based medtech start-up, has raised more than $100 million to advance its non-invasive brain monitoring technology, with the latest $60 million round led by Plural, a London-based early-stage venture fund.  Industry sources have told HBI that the minimally invasive and implantable medtech sector is particularly attractive. It offers strong dual appeal: improving patient outcomes while enhancing operational efficiency through automation and workforce optimisation.
October 23, 2025

Bupa acquires third London hospital

British multinational health insurer Bupa is buying King Edward VII’s Hospital, a 56-bed facility in the Harley Street area in London. This follows the recent acquisition of New Victoria Hospital, a 33-bed facility in Kingston Upon Thames. Both acquisitions are driven by Bupa’s strategic intent to keep 40% of referrals within its provider network. However, we hear Bupa may struggle to attract the consultants, and therefore enough patients, that would be required to achieve this.
October 23, 2025

Interview: Andrew Neville, Inflexion

Inflexion is a European mid-market private equity firm that invests in multiple healthcare sub sectors — medical devices, outsourced pharma services, specialty pharma products and animal health. In a conversation with HBI, Andrew Neville, Partner, explained what Inflexion is looking for in the businesses it invests in, and offers case studies of two companies currently in its portfolio.
October 17, 2025

Fresenius accelerates Vamed sell-off

Healthcare conglomerate Fresenius Group has decided to split the sale of the Austrian branch of subsidiary Vamed into two steps, in order to simplify and accelerate the process. 
October 16, 2025
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us